Ublituximab (TG-1101), a Novel Anti-CD20 Monoclonal for Rituximab Relapsed/Refractory B-cell Malignancies.

Drug Category: Array
Conference Category: Array
Lead Author: Changchun D, O'Connor O, et al.
Published Date: 14/06/2013
Download Link: /wp-content/uploads/2019/03/EHA2013PosterP325.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top